COVID-19 Related News
COVID-19 antibody surveillance programme launched in the UK
A new antibody surveillance scheme will be introduced in the UK to improve understanding of immunity against COVID-19 from vaccination and infection.
Launching on Tuesday...
COVID-19 vaccines are still effective against Delta variant, study confirms
Two COVID-19 vaccine doses provide the most effective protection from the Delta variant in the UK, a new study has shown.
Researchers from the University...
On-site vaccinations and phased return could make universities safer
Offering COVID-19 vaccines on campus and introducing phased returns in the autumn is key to making universities safer, public health experts have said.
In an...
Cannabis use in Australia rose significantly during first COVID-19 lockdown
Cannabis use in Australia spiked during the first COVID-19 lockdown period whilst methamphetamine use fell dramatically, a study has found.
Research led by the University...
COVID-19 vaccine benefits outweigh risk of Bell’s palsy, say researchers
The benefits and efficacy of COVID-19 vaccines far outweigh the minimal risk of developing Bell’s palsy, researchers have said.
Following the first large-scale population-based study...
Blood clotting could be root cause of long COVID, research suggests
Blood clotting may be the main cause of long COVID syndrome, the findings from a recent study have indicated.
The study, led by researchers from...
Organ support therapy ADVOS can effectively treat COVID-19 patients
A new study has demonstrated the efficacy of ADVOS organ support therapy in successfully treating COVID-19 patients.
ADVOS, the new blood purification procedure from ADVITOS,...
Pre-clinical trials show intranasal COVID-19 vaccine reduces infection risk
Researchers have made a significant breakthrough in the development of an intranasal COVID-19 vaccine.
Scientists from Lancaster University have carried out pre-clinical trials of a...
COVIDDRIVE: A new initiative to analyse COVID-19 vaccine effectiveness
Europe’s COVID-19 vaccine effectiveness is set to be intrinsically analysed by COVIDRIVE – a new public-private partnership implemented to investigate the medication’s efficacy.
The novel...
Common tapeworm drugs may provide new COVID-19 treatment
A novel investigation has indicated that a range of widely utilised tapeworm drugs may also work as an effective COVID-19 treatment.
The research, conducted by...
Defence Therapeutics: At the forefront of biotech innovation
In this article, we examine the future landscape of the Biotech sector, looking at the companies Defence Therapeutics, MorphoSys, BioNTech, and Pfizer.
Infectious diseases are...
Cholesterol drug could reduce SARS-CoV-2 infection by up to 70%
Scientists have identified a licensed drug that they say could significantly reduce the risk of COVID-19 infection.
An international study, led by the University of...
Double vaccine dose halves COVID-19 infection risk, study estimates
COVID-19 infection rates in England are three times lower in double vaccinated people, the findings from the recent REACT-1 report have revealed.
The latest findings...
Long-lasting COVID-19 symptoms in children are rare, study confirms
Children with COVID-19 are less likely to suffer from long-lasting symptoms than adults with the infection, a new UK study has shown.
In the study...
B Medical Systems: Reliable cold chain solutions for every need
Discover more about B Medical Systems’ wide range of solutions available to support the vaccine cold chain, medical refrigeration, and blood management fields.
B Medical...
Long COVID rehabilitation project receives £1.1 million in funding
£1.1 million of UK government funding has been awarded to support a research project launched to help people with long COVID.
The new project, known...
Health Europa Quarterly Issue 18
Welcome to Health Europa Quarterly Issue 18, which looks at the ever-changing updates and response to COVID-19; covering everything from digital health to gender...
Early COVID-19 symptoms differ among age groups, research reveals
Early symptoms of the COVID-19 infection vary depending on factors such as age and gender, new research using machine learning has found.
A study led...
The pharmaceutical industry’s response to COVID-19
Nathalie Moll, Director General of the EFPIA, discusses the changes the pharmaceutical industry has implemented to support the healthcare sector through COVID-19.
The European Federation...
AI tool reveals link between blood glucose and severe COVID-19
By using an artificial intelligence (AI) tool, scientists have found that blood glucose levels play a key role in the severity of COVID-19.
A research...